Toviaz (fesoterodine) is used to treat overactive bladder with symptoms of urinary frequency, urgency, and incontinence in adults, and neurogenic detrusor overactivity in children. Includes Toviaz side effects, interactions and indications.

2024年7月17日 · What is fesoterodine used for? Fesoterodine is commonly used to treat the following conditions. Overactive bladder, when you have an urgent need to pee even if your bladder is not full, wetting...

2024年1月15日 · Fesoterodine fumarate (Toviaz) is an anticholinergic urinary antispasmodic. It relieves symptoms of overactive bladder (OAB) in adults. Brand name Toviaz is also approved to treat neurogenic detrusor overactivity (NDO) in children. Fesoterodine (Toviaz) is an extended-release tablet that's taken by mouth once a day.

TOVIAZ is used to increase the amount of urine your bladder can hold and reduce urine leakage. It is not known if TOVIAZ is safe and effective in children younger than 6 years of age or with a body weight 55 pounds (25-kg) or less. Who should not take TOVIAZ? are allergic to TOVIAZ or any of its ingredients.

in adults to treat symptoms of a condition called overactive bladder (OAB), including urge urinary incontinence (leaking or wetting accidents due to a strong need to urinate), urinary urgency (having a strong need to urinate right away), or urinary frequency (having to urinate too often).

2024年12月12日 · The recommended starting dosage of Toviaz in adults is 4 mg orally once daily. Based upon individual response and tolerability, increase to the maximum dosage of Toviaz 8 mg once daily. For administration instructions, see Dosage and Administration (2.6). Pediatric Patients Weighing Greater than 25 kg and up to 35 kg.

2024年9月9日 · Toviaz is indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Toviaz is indicated for the treatment of neurogenic detrusor overactivity (NDO) in pediatric patients 6 years of age and older with a body weight greater than 25 kg.

in adults to treat symptoms of a condition called overactive bladder (OAB), including urge urinary incontinence (leaking or wetting accidents due to a strong need to urinate), urinary urgency (having a strong need to urinate right away), or urinary frequency (having to urinate too often).

2012年4月6日 · Toviaz® is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. The recommended starting dose of Toviaz is 4 mg once daily. Based upon individual response and tolerability, the dose may be increased to 8 mg once daily. The daily dose of Toviaz should not ...

Indicated for overactive bladder with urge incontinence, urgency, and frequency. 4 mg PO qDay; may increase 8 mg PO qDay based upon individual response and tolerability. Concomitant use with CYP3A4...